IP Library Granted Patent US 10,258,654
Granted Patent B2
US 10,258,654 · App. 15/714,969 · Granted Apr 16, 2019

Non-pathogenic F18

Inventors: John Morris Fairbrother (Saint-Hyacinthe, CA); Éric Nadeau (Otterburn Park, CA); Clarisse Desautels (Saint-Hyacinthe, CA)
Assignee: PREVTEC MICROBIA INC.
A61K35/74C12N1/20C12R1/19Y02A50/473
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,258,654
App. No.
15/714,969
Granted
Apr 16, 2019
Kind
B2
Abstract

There is provided an isolated E. coli strain deposited at the International Depositary Authority of Canada (IDAC) on Jun. 20, 2013 and attributed accession number 200613-01. There is also provided methods of using this strain for preventing edema disease or diarrhea caused by an F18 pathogenic E. coli infection in an animal.

Claims (18)

1. A composition comprising a mixture of live Escherichia coli strains including an F4-expressing strain and an F18-expressing strain, the mixture being capable of reducing F18 intestine colonization in an animal upon intestinal delivery of the mixture more effectively relative to a comparison composition that is identical to said composition except for not including said F4-expressing strain, wherein the F18-expressing strain is the strain deposited at the International Depositary Authority of Canada (IDAC) on Jun. 20, 2013, and attributed accession number 200613-01 and the F4-expressing strain is the strain deposited at the IDAC on Jan. 21, 2005, and attributed accession number IDAC 210105-01.

2. The composition according to claim 1 , wherein the F18-expressing strain is in an amount sufficient for administration to an animal of from about 5×10 6 to about 3×10 10 CFU per animal.

3. The composition according to claim 1 , wherein the F18-expressing strain is in an amount sufficient for administration to an animal of at least 5×10 8 CFU per animal.

4. The composition according to claim 1 , wherein the F18-expressing strain is in an amount sufficient for administration to an animal of at least 1×10 9 CFU per animal.

5. The composition according to claim 1 , wherein the F18-expressing strain is in an amount sufficient for administration to an animal of at least 5×10 9 CFU per animal.

6. The composition according to claim 1 , wherein the F18-expressing strain is in an amount sufficient for administration to an animal of at least 3×10 8 CFU per animal.

7. The composition according to claim 1 , the composition comprising each strain in an amount sufficient for respective administration to an animal of at least 5×10 8 CFU per animal.

8. The composition according to claim 1 , wherein the composition is formulated for delivery to the intestine of an animal.

9. The composition according to claim 1 , wherein the composition is formulated for oral administration to an animal.

10. The composition according to claim 8 , wherein the animal is a pig.

11. The composition according to claim 10 , wherein the pig is a post-weaning pig.

12. The composition according to claim 10 , wherein the pig is a pre-weaning pig.

13. The composition according to claim 9 , wherein the animal is a pig.

14. The composition according to claim 13 , wherein the pig is a post-weaning pig.

15. The composition according to claim 13 , wherein the pig is a pre-weaning pig.

16. The composition according to claim 1 , further comprising a feed acceptable carrier.

17. The composition according to claim 16 , wherein the feed acceptable carrier is a solid carrier.

18. The composition according to claim 16 , wherein the feed acceptable carrier is a liquid carrier.

Assignments (7)
MERGER Recorded Aug 28, 2020
From: PREVTEC MICROBIA INC
To: ELANCO CANADA LIMITED
Reel/Frame 053633/0994 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2020
From: PREVTEC MICROBIA INC.
To: ELANCO CANADA LIMITED
Reel/Frame 053294/0879 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2019
From: VALORISATION-RECHERCHE, LIMITED PARTNERSHIP
To: PREVTEC MICROBIA INC.
Reel/Frame 049454/0191 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2019
From: UNIVERSITE DE MONTREAL
To: VALORISATION-RECHERCHE, LIMITED PARTNERSHIP
Reel/Frame 049454/0198 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2019
From: PREVTEC MICROBIA INC.
To: PREVTEC MICROBIA INTERNATIONAL INC.
Reel/Frame 049672/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2019
From: PREVTEC MICROBIA INTERNATIONAL INC.
To: PREVTEC MICROBIA INC.
Reel/Frame 049451/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2019
From: FAIRBROTHER, JOHN M.; NADEAU, ERIC; DESAUTELS, CLARISSE
To: UNIVERSITE DE MONTREAL
Reel/Frame 049451/0795 →
Continuity (4)
Continuation 15247442 · Aug 25, 2016
Continuation 14414964
Provisional Application 61674179 · Jul 20, 2012
Related Publication 20180008651A1 · Jan 11, 2018